[1]
2024. Cost of Hepatocellular Carcinoma from the Payer’s Perspective in Türkiye: Results of a Delphi Panel Analysis. Global Journal of Medical and Pharmaceutical Sciences. 3, 09 (Sep. 2024), 13–24. DOI:https://doi.org/10.55640/gjmps/Volume03Issue09-03.